FCM
ELV icon

Farallon Capital Management’s Elevance Health ELV Stock Holding History

Farallon Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-381,330
Closed -$166M – 163
2023
Q3 		$166M Sell
381,330
-64,000
-14% -$29M 0.77% 37
2023
Q2 		$198M Sell
445,330
-228,300
-34% -$105M 0.99% 33
2023
Q1 		$310M Buy
673,630
+39,330
+6% +$18.7M 1.69% 20
2022
Q4 		$325M Sell
634,300
-167,100
-21% -$84.8M 1.92% 18
2022
Q3 		$364M Sell
801,400
-25,082
-3% -$12M 2% 9
2022
Q2 		$399M Buy
826,482
+57,707
+8% +$28.5M 2.16% 8
2022
Q1 		$378M Buy
768,775
+13,715
+2% +$6.27M 1.82% 14
2021
Q4 		$350M Sell
755,060
-99,905
-12% -$42M 1.75% 19
2021
Q3 		$319M Buy
854,965
+204,965
+32% +$77.9M 1.49% 24
2021
Q2 		$248M Sell
650,000
-175,000
-21% -$66.9M 1.01% 35
2021
Q1 		$296M Sell
825,000
-450,000
-35% -$145M 1.47% 24
2020
Q4 		$409M Hold
1,275,000
– – 2.46% 12
2020
Q3 		$342M Buy
1,275,000
+25,000
+2% +$6.73M 2.37% 13
2020
Q2 		$329M Hold
1,250,000
– – 2.63% 11
2020
Q1 		$284M Hold
1,250,000
– – 2.44% 15
2019
Q4 		$378M Buy
1,250,000
+187,117
+18% +$51.5M 2.55% 7
2019
Q3 		$255M Buy
1,062,883
+12,883
+1% +$3.53M 1.93% 13
2019
Q2 		$296M Buy
1,050,000
+225,000
+27% +$61.5M 1.93% 11
2019
Q1 		$237M Sell
825,000
-225,000
-21% -$65.1M 1.78% 16
2018
Q4 		$276M Buy
1,050,000
+15,000
+1% +$4.12M 2.02% 16
2018
Q3 		$284M Hold
1,035,000
– – 1.68% 16
2018
Q2 		$246M Buy
1,035,000
+45,000
+5% +$10.4M 1.52% 21
2018
Q1 		$218M Buy
990,000
+167,000
+20% +$39.2M 1.51% 20
2017
Q4 		$185M Buy
823,000
+613,000
+292% +$131M 1.5% 19
2017
Q3 		$39.9M Hold
210,000
– – 0.35% 46
2017
Q2 		$39.5M Buy
+210,000
New +$37.7M 0.41% 42

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Farallon Capital Management's ELV Position: Q4 2023 in Review

Farallon Capital Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 381,330 shares — an estimated $166M sold.

Farallon Capital Management first reported a position in ELV in Q2 2017 and held it in 26 quarters. The position peaked at $409M in Q4 2020. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Farallon Capital Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Farallon Capital Management sold 381,330 Elevance Health shares in Q4 2023, an estimated $166M.
  • Farallon Capital Management first reported a position in Elevance Health in Q2 2017 and held it in 26 quarters.
  • Farallon Capital Management's Elevance Health position peaked at $409M in Q4 2020.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Farallon Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.